News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
79,560 Results
Type
Article (9458)
Company Profile (52)
Press Release (70050)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (21928)
Career Advice (105)
Deals (3058)
Drug Delivery (9)
Drug Development (12266)
Employer Resources (14)
FDA (1725)
Job Trends (2217)
News (37986)
Policy (3190)
Tag
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2026 Genetown Elite (1)
Academia (646)
Accelerated approval (1)
Adcomms (5)
Allergies (3)
Alliances (6984)
ALS (20)
Alzheimer's disease (259)
Antibody-drug conjugate (ADC) (7)
Approvals (1725)
Artificial intelligence (41)
Autoimmune disease (2)
Automation (2)
Bankruptcy (14)
Best Places to Work (2113)
BIOSECURE Act (2)
Biosimilars (6)
Biotechnology (47)
Bladder cancer (8)
Brain cancer (8)
Breast cancer (33)
Cancer (297)
Cardiovascular disease (33)
Career advice (92)
Career pathing (1)
CAR-T (32)
Cell therapy (102)
Clinical research (9335)
Collaboration (173)
Compensation (70)
Complete response letters (4)
COVID-19 (369)
CRISPR (24)
C-suite (30)
Cystic fibrosis (59)
Data (414)
Depression (2)
Diabetes (26)
Diagnostics (1484)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (28)
Drug pricing (4)
Duchenne muscular dystrophy (45)
Earnings (6743)
Editorial (5)
Employer branding (3)
Employer resources (13)
Events (11781)
Executive appointments (80)
FDA (1906)
Featured Employer (12)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (110)
Gene editing (66)
Generative AI (2)
Gene therapy (153)
GLP-1 (68)
Government (482)
Grass and pollen (1)
Guidances (6)
Healthcare (2383)
Huntington's disease (7)
IgA nephropathy (2)
Immunology and inflammation (10)
Indications (5)
Infectious disease (388)
Inflammatory bowel disease (22)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (10)
Interviews (14)
IPO (1566)
IRA (1)
Job creations (265)
Job search strategy (89)
Kidney cancer (1)
Labor market (2)
Layoffs (53)
Legal (389)
Liver cancer (8)
Lung cancer (36)
Lymphoma (30)
Management (1)
Manufacturing (33)
MASH (2)
Medical device (295)
Medtech (295)
Mergers & acquisitions (1564)
Metabolic disorders (81)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (366)
NextGen: Class of 2025 (733)
Non-profit (664)
Northern California (444)
Now hiring (4)
Obesity (51)
Opinion (36)
Ovarian cancer (1)
Pain (10)
Pancreatic cancer (11)
Parkinson's disease (34)
Partnered (2)
Patents (19)
Patient recruitment (11)
People (7078)
Pharmaceutical (3)
Phase I (3565)
Phase II (4272)
Phase III (3019)
Pipeline (175)
Policy (7)
Postmarket research (213)
Preclinical (1593)
Press Release (18)
Prostate cancer (6)
Psychedelics (3)
Radiopharmaceuticals (16)
Rare diseases (183)
Real estate (494)
Recruiting (3)
Regulatory (2638)
Reports (8)
Research institute (770)
Resumes & cover letters (11)
Rett syndrome (4)
RNA editing (3)
RSV (1)
Schizophrenia (5)
Series A (24)
Series B (13)
Service/supplier (1)
Sickle cell disease (20)
Southern California (300)
Special edition (2)
Spinal muscular atrophy (132)
Sponsored (5)
Startups (612)
Supply chain (2)
Tariffs (1)
The Weekly (3)
United States (3334)
Vaccines (69)
Venture capitalists (4)
Weight loss (10)
Women's health (2)
Date
Today (13)
Last 7 days (55)
Last 30 days (356)
Last 365 days (5248)
2025 (1401)
2024 (5519)
2023 (5903)
2022 (7938)
2021 (8301)
2020 (6775)
2019 (5510)
2018 (4126)
2017 (4241)
2016 (3803)
2015 (4368)
2014 (3074)
2013 (2441)
2012 (2221)
2011 (2198)
2010 (1938)
Location
Africa (91)
Alabama (3)
Alaska (2)
Arizona (14)
Arkansas (1)
Asia (3783)
Australia (757)
California (910)
Canada (178)
China (49)
Colorado (32)
Connecticut (39)
Delaware (7)
Europe (11018)
Florida (93)
Georgia (6)
Idaho (4)
Illinois (27)
India (2)
Indiana (78)
Iowa (1)
Japan (34)
Kansas (5)
Kentucky (4)
Louisiana (2)
Maine (2)
Maryland (107)
Massachusetts (925)
Michigan (46)
Minnesota (9)
Missouri (3)
Montana (2)
Nebraska (4)
Nevada (8)
New Hampshire (3)
New Jersey (172)
New Mexico (3)
New York (228)
North Carolina (150)
North Dakota (4)
Northern California (444)
Ohio (31)
Oklahoma (1)
Oregon (4)
Pennsylvania (201)
Rhode Island (4)
South America (117)
South Carolina (1)
Southern California (300)
Tennessee (1)
Texas (112)
Utah (66)
Virginia (29)
Washington D.C. (7)
Washington State (96)
Wisconsin (6)
79,560 Results for "sophia genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
April 8, 2025
·
7 min read
Genetown
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform
SOPHiA GENETICS, a cloud-native healthcare technology company and a leader in data-driven medicine, announced that Kepler Uniklinikum, Austria’s second largest hospital, is live on SOPHiA GENETICS’ platform.
June 13, 2024
·
4 min read
Genetown
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, announced its new Residual Acute Myeloid Application.
June 24, 2024
·
5 min read
Genetown
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
SOPHiA GENETICS SA is pleased to announce that its annual general meeting of shareholders was held at the Company’s headquarters, La Piece 12, 1180 Rolle/VD, Switzerland, earlier at 14:00 CEST.
June 24, 2024
·
2 min read
Business
SOPHiA GENETICS Reports First Quarter 2024 Results
SOPHiA GENETICS, a cloud-native software company and leader in data-driven medicine, reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
21 min read
Genetown
SOPHiA GENETICS Supports Genetic Testing in Brazil
SOPHiA GENETICS announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian population, is now live on the SOPHiA DDM™ Platform.
January 25, 2024
·
4 min read
Genetown
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDM™.
April 23, 2024
·
6 min read
Press Releases
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
September 12, 2024
·
4 min read
Genetown
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
SOPHiA GENETICS (Nasdaq: SOPH) today announced the University of Saskatchewan (USask) as its first HRD customer in Canada.
March 20, 2024
·
6 min read
Business
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
SOPHiA GENETICS reported financial results for its fourth quarter and fiscal year ended December 31, 2023.
March 5, 2024
·
21 min read
1 of 7,956
Next
